UniQure N.V. (QURE) Upgraded to Overweight as Huntington’s Disease Program Advances

TheFly reported connected June 18 that Barclays raised its standing connected QURE to Overweight from Equal Weight and accrued its terms people to $65 from $25. The steadfast viewed QURE's planned Biologics License Application (BLA) submission for Huntington's illness successful the 3rd 4th arsenic a important affirmative catalyst. Barclays besides improved its probability appraisal for the program's occurrence and highlighted the imaginable worth of Huntington's illness opportunity, estimating important upside for shares based connected the anticipation of a multibillion-dollar highest income opportunity.

Separately, connected June 19, UniQure N.V. (NASDAQ:QURE) announced preliminary six-month follow-up findings from the archetypal low-dose radical of its ongoing Phase I/IIa survey evaluating AMT-260, an investigational cistron therapy for refractory mesial temporal lobe epilepsy. Data from the six participants showed that 3 patients experienced notable reductions successful disabling seizures during months 4 done six, with decreases ranging from 79% to implicit simplification compared with baseline. The remaining patients showed mixed seizure changes during the follow-up period. No superior adverse events linked to AMT-260 oregon the surgical process were reported, and observed broadside effects were mild to moderate, with headache being the astir common. Enrollment continues successful a higher-dose cohort.

UniQure N.V. (NASDAQ:QURE) is simply a biopharmaceutical institution processing one-time AAV-based cistron therapies for terrible familial and cardinal tense strategy diseases, aiming to present perchance curative treatments.

While we admit the imaginable of QURE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.